123 related articles for article (PubMed ID: 10779509)
1. Coreceptor function of mutant human CD4 molecules without affinity to gp120 of human immunodeficiency virus.
Tachibana M; Siddiqi MA; Ikegami Y; Eshima K; Shirota-Someya Y; Tahara-Hanaoka S; Koito A; Iizuka M; Shinohara N
J Biol Chem; 2000 Jul; 275(27):20288-94. PubMed ID: 10779509
[TBL] [Abstract][Full Text] [Related]
2. Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.
Platt EJ; Madani N; Kozak SL; Kabat D
J Virol; 1997 Feb; 71(2):883-90. PubMed ID: 8995604
[TBL] [Abstract][Full Text] [Related]
3. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly.
Piatier-Tonneau D; Gastinel LN; Moussy G; Bénichou B; Amblard F; Vaigot P; Auffray C
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6858-62. PubMed ID: 1713692
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule.
Wang JH; Meijers R; Xiong Y; Liu JH; Sakihama T; Zhang R; Joachimiak A; Reinherz EL
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10799-804. PubMed ID: 11535811
[TBL] [Abstract][Full Text] [Related]
6. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
Platt EJ; Kuhmann SE; Rose PP; Kabat D
J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the gp120-binding area of murine and human CD4 molecules.
Siddiqi MA; Tachibana M; Ohta S; Ikegami Y; Tahara-Hanaoka S; Huang YY; Shinohara N
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):7-12. PubMed ID: 8989204
[TBL] [Abstract][Full Text] [Related]
9. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
[TBL] [Abstract][Full Text] [Related]
10. Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120.
Bitton N; Verrier F; Debré P; Gorochov G
Eur J Immunol; 1998 Dec; 28(12):4177-87. PubMed ID: 9862354
[TBL] [Abstract][Full Text] [Related]
11. CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor.
Yuan W; Craig S; Si Z; Farzan M; Sodroski J
J Virol; 2004 May; 78(10):5448-57. PubMed ID: 15113923
[TBL] [Abstract][Full Text] [Related]
12. Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity.
Dirckx L; Lindemann D; Ette R; Manzoni C; Moritz D; Mous J
Virus Res; 1990 Dec; 18(1):9-20. PubMed ID: 2082620
[TBL] [Abstract][Full Text] [Related]
13. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
[TBL] [Abstract][Full Text] [Related]
14. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
16. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
Broder CC; Berger EA
J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
[TBL] [Abstract][Full Text] [Related]
17. The MHC-binding and gp120-binding functions of CD4 are separable.
Lamarre D; Ashkenazi A; Fleury S; Smith DH; Sekaly RP; Capon DJ
Science; 1989 Aug; 245(4919):743-6. PubMed ID: 2549633
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
Dey B; Del Castillo CS; Berger EA
J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
[TBL] [Abstract][Full Text] [Related]
19. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.
Ashkenazi A; Presta LG; Marsters SA; Camerato TR; Rosenthal KA; Fendly BM; Capon DJ
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7150-4. PubMed ID: 2402498
[TBL] [Abstract][Full Text] [Related]
20. Differential level in co-down-modulation of CD4 and CXCR4 primed by HIV-1 gp120 in response to phorbol ester, PMA, among HIV-1 isolates.
Tahara-Hanaoka S; Ushijima Y; Tarui H; Wada M; Hara T; Imanishi S; Yamaguchi T; Hattori T; Nakauchi H; Koito A
Microbiol Immunol; 2000; 44(6):489-98. PubMed ID: 10941932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
